Outbreak of pyrazinamide-monoresistant tuberculosis identified using genotype cluster and social media analysis

被引:8
作者
Thomas, T. A. [1 ]
Heysell, S. K. [1 ]
Houpt, E. R. [1 ]
Moore, J. L. [2 ]
Keller, S. J. [2 ]
机构
[1] Univ Virginia, Charlottesville, VA 22908 USA
[2] Virginia Dept Hlth, Richmond, VA USA
基金
美国国家卫生研究院;
关键词
drug resistance; pncA protein; Virginia; pediatrics; social media; RESISTANT MYCOBACTERIUM-TUBERCULOSIS; PNCA; SUSCEPTIBILITY; EPIDEMIOLOGY; MUTATIONS;
D O I
10.5588/ijtld.13.0663
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
SETTING: Monoresistance to pyrazinamide (PZA) has infrequently been associated with Mycobacterium tuberculosis. OBJECTIVE: To report an outbreak of PZA-monoresistant M. tuberculosis in Virginia involving two genotype clusters from December 2004 to August 2010. RESULTS: Thirty cases were identified involving a predominantly young, US-born population with histories of substance use and incarceration and a large proportion of children aged <15 years (n= 6, 20%); of these, 23 cases (77%) were culture-confirmed as M. tuberculosis complex. DNA fingerprinting and molecular analysis of the PZA resistance gene, pncA, demonstrated a clonal strain that was not M. bovis. Genotypic data provided the initial link between seemingly unrelated cases, and helped reveal a historic genotype cluster of cases from 2004. Further genotype cluster and contact investigation procedures, including the novel use of the social networking website Facebook.com, revealed additional links between the 2004 and 2009 genotype clusters and described an ongoing, extensive outbreak necessitating an enhanced screening and treatment protocol for contacts. CONCLUSIONS: This outbreak demonstrates how tuberculosis can spread through a young, vulnerable population. The use of genotypic data and the novel incorporation of social media investigations were critical to understanding the settings and context of infectivity.
引用
收藏
页码:552 / 558
页数:7
相关论文
共 28 条
[1]  
American Thoracic Society, 2003, MMWR Recomm Rep, V52, P1
[2]   Limited Utility of Name-Based Tuberculosis Contact Investigations among Persons Using Illicit Drugs: Results of an Outbreak Investigation [J].
Asghar, Rana Jawad ;
Patlan, David E. ;
Miner, Mark C. ;
Rhodes, Halsey D. ;
Solages, Anthony ;
Katz, Dolly J. ;
Beall, David S. ;
Ijaz, Kashef ;
Oeltmann, John E. .
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2009, 86 (05) :776-780
[3]  
Basinger E, 2009, TB DETECTION CHARACT
[4]   Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis [J].
Campbell, Patricia J. ;
Morlock, Glenn P. ;
Sikes, R. David ;
Dalton, Tracy L. ;
Metchock, Beverly ;
Starks, Angela M. ;
Hooks, Delaina P. ;
Cowan, Lauren S. ;
Plikaytis, Bonnie B. ;
Posey, James E. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (05) :2032-2041
[5]  
Centers for Disease Control and Prevention Division of Tuberculosis Elimination, 2013, GENTYPE NEW GEN TERM
[6]   Potential for Erroneous Results Indicating Resistance When Using the Bactec MGIT 960 System for Testing Susceptibility of Mycobacterium tuberculosis to Pyrazinamide [J].
Chedore, Pamela ;
Bertucci, Lina ;
Wolfe, Joyce ;
Sharma, Meenu ;
Jamieson, Frances .
JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (01) :300-301
[7]   pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis:: Spread of a monoresistant strain in Quebec, Canada [J].
Cheng, SJ ;
Thibert, L ;
Sanchez, T ;
Heifets, L ;
Zhang, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) :528-532
[8]   Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis? [J].
de Jong, BC ;
Onipede, A ;
Pym, AS ;
Gagneux, S ;
Aga, RS ;
DeRiemer, K ;
Small, PM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (07) :3530-3532
[9]   Infodemiology and Infoveillance Tracking Online Health Information and Cyberbehavior for Public Health [J].
Eysenbach, Gunther .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2011, 40 (05) :S154-S158
[10]   Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States [J].
Hannan, MM ;
Desmond, EP ;
Morlock, GP ;
Mazurek, GH ;
Crawford, JT .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (02) :647-650